Your browser doesn't support javascript.
loading
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
Zhang, Puran; Gu, Yun; Wang, Jieti; Lv, Kunpeng; Lin, Chao; Zhang, Heng; Li, He; He, Hongyong; Li, Ruochen; Liu, Hao; Xu, Jiejie.
Afiliación
  • Zhang P; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Gu Y; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Wang J; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lv K; Department of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Lin C; NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Zhang H; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li H; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • He H; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li R; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu H; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu J; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Int J Cancer ; 153(1): 224-237, 2023 07 01.
Article en En | MEDLINE | ID: mdl-36799619

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Receptores de Complemento Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Receptores de Complemento Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China